Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX29 Compared With HLX11
Clinical trial NCT07776132 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07776132
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-05
- Primary completion
- 2026-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.